Bon Opus Biosciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Bon Opus Biosciences is a private, early-revenue contract research organization (CRO) providing essential research services to the scientific community. Its core business is the custom production of recombinant proteins, recombinant antibodies, and peptides, serving over 1,000 organizations globally. The company emphasizes close client collaboration and technical support to deliver reliable, publication-quality reagents. As a growing startup, it is actively hiring to expand its commercial and operational teams.

AntibodiesBiologics

Technology Platform

Integrated service platform for custom recombinant protein/antibody production and peptide synthesis, including gene synthesis, expression, purification, and characterization.

Opportunities

The growing demand for highly specific, custom research reagents from academic and biopharmaceutical R&D presents a sustained market.

Expansion into adjacent service lines like assay development or establishing preferred provider partnerships with larger biotech firms could drive growth.

Leveraging its publication record and testimonials can help capture market share from less service-oriented competitors.

Risk Factors

Faces intense competition from both large catalog suppliers and other niche CROs.

Revenue is vulnerable to fluctuations in client R&D budgets and grant funding.

Operational scalability poses a risk, as growth must not compromise the high-touch service and quality control that define its value proposition.

Competitive Landscape

Competes in the fragmented life science tools and services market. Key competitors include the custom service divisions of large players (e.g., Thermo Fisher, GenScript), specialized protein production CROs, and academic core facilities. Bon Opus differentiates through a strong emphasis on partnership, responsive project management, and technical problem-solving rather than competing solely on price or catalog breadth.

More companies in Proteomics & Protein Engineering →More companies in United States →